Cognitive Deficits and Local Metabolic Changes in Dementia of the Alzheimer Type

  • J. V. Haxby
Conference paper
Part of the Research and Perspectives in Alzheimer’s Disease book series (ALZHEIMER)

Summary

Relations between neuropsychological and regional cerebral metabolic alterations were studied cross-sectionally and longitudinally in patients with dementia of the Alzheimer type and were compared to controls. Reductions in regional cerebral metabolism, measured in the resting state with positron emission tomography and [18F]fluorodeoxyglucose, were greatest in the association cortices relative to the primary sensory and motor cortices and to the thalamus and basal ganglia. Individual patients demonstrated different patterns of association cortex metabolic reductions. Reductions in homologous right and left hemisphere association regions were often asymmetric. Parietal and frontal metabolic reductions were also often disproportionate relative to each other. Neuropsychological impairments in patients with dementia of the Alzheimer type were also selective and heterogeneous. Memory impairment was often the first symptom followed by impaired ability to maintain attention to complex or shifting sets. As the disease progressed, language and visuospatial functions became impaired. Whereas the memory impairment was usually global and severe, patterns of nonmemory impairments varied markedly from patient to patient. For example, some patients had disproportionately severe language impairments relative to milder visuospatial impairments and other patients demonstrated the opposite pattern. In patients with moderate dementia of the Alzheimer type, patterns of nonmemory impairments were related to the distribution of association cortex metabolic reductions. At initial evaluation, mildly impaired patients did not have significant nonmemory language and visuospatial impairments but did have significant neocortical metabolic reductions that were not correlated with neuropsychological test scores. After a mean of 2 years of longitudinal study, significant language and visuospatial impairments developed, and right-left metabolic asymmetries were significantly correlated with visuospatial-language discrepancies. These results suggest that neocortical metabolic abnormalities can be observed with positron emission tomography before associated impairments of neocortically mediated visuospatial and language functions are demonstrable.

Keywords

Memory Impairment Association Cortex Neuropsychological Impairment Moderate Dementia Visuospatial Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ball MJ (1976) Neurofibrillary tangles and the pathogenesis of dementia: a quantitative study. Neuropathol Appl Neurobiol 2:395–410CrossRefGoogle Scholar
  2. Benton AL (1973) The measurement of aphasic disorders. In: Velasquez AC (ed) Aspectos Patologicos del Langage. Centro Neuropsicologico, Lima, PeruGoogle Scholar
  3. Duara R, Grady CL, Haxby JV, Sundaram M, Cutler NR, Heston L, Morre A, Schlageter NL, Larson S, Rapoport SI (1986) Positron emission tomography in Alzheimer’s disease. Neurology 36:879–887PubMedGoogle Scholar
  4. Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-Mental State’: a practical method for grading the mental state of patients for the clinician. J Psychiat Res 12:189–198PubMedCrossRefGoogle Scholar
  5. Friedland RP, Budinger TF, Koss E, Ober BA (1985) Alzheimer’s disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 53:235–240PubMedCrossRefGoogle Scholar
  6. Golden CJ (1978) The Stroop color and word test: a manual for clinical and experimental uses. Stoelting, ChicagoGoogle Scholar
  7. Grady CL, Haxby JV, Schlageter NL, Berg G, Rapoport SI (1986) Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology 36:1390–1392PubMedGoogle Scholar
  8. Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, Friedland RP, Rapoport SI (1988) A longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 10:576–596PubMedCrossRefGoogle Scholar
  9. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI (1985) Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer’s disease. J Cereb Blood Flow Metabol 5:193–200CrossRefGoogle Scholar
  10. Haxby JV, Grady CL, Duara R, Schlageter NL, Berg G, Rapoport SI (1986) Neocortical metabolic abnormalities precede non-memory cognitive deficits in early Alzheimer-type dementia. Arch Neurol 43:882–885PubMedGoogle Scholar
  11. Haxby JV, Grady CL, Friedland RP, Rapoport SI (1987) Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: longitudinal confirmation. J Neural Transm 24[Suppl]:49–51Google Scholar
  12. Haxby JV, Grady CL, Koss E, Horwitz B, Schapiro M, Friedland RP, Rapoport SI (1988) Heterogeneous anterior-posterior metabolic patterns in Alzheimer’s type dementia. Neurology 38:1853–1863PubMedGoogle Scholar
  13. Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI (1987) Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer’s disease. Brain Res 407:294–306PubMedCrossRefGoogle Scholar
  14. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment in Alzheimer’s disese. Ann Neurol 20:472–481PubMedCrossRefGoogle Scholar
  15. Mattis S (1976) Mental status examination for organic mental syndrome in the elderly patient. In: Bellack L, Karasu TB (eds) Geriatric psychiatry, Grune & Stratton, New York, pp 77–121Google Scholar
  16. McGeer PL, Kamo H, Harrop R, Li DKB, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB, Martin WBW, Pate BD, Rogers JG, Ruth TJ, Sayre CI, Stoessl AJ (1986) Positron emission tomography in patients with clinically diagnosed Alzheimer’s disease. Can Med Assoc J 134:597–607Google Scholar
  17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMedGoogle Scholar
  18. Mesulam MM (1981) A cortical network for directed attention and unilateral neglect. Ann Neurol 10:309–325PubMedCrossRefGoogle Scholar
  19. Milner B (1971) Interhemispheric difference in the localization of psychological process in man. Br Med Bull 27:272–277PubMedGoogle Scholar
  20. Mishkin M, Appenzeller T (1987) The anatomy of memory. Sci Am 256:80–89Google Scholar
  21. Porteus SD (1965) Porteus Maze Test: fifty years application. Pacific Books, Palo AltoGoogle Scholar
  22. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276Google Scholar
  23. Wechsler DA (1945) A standardized memory scale for clinical use. J Psychol 19:87–95CrossRefGoogle Scholar
  24. Wechsler DA (1955) Wechsler Adult Intelligence Scale. Psychological Corporation, New YorkGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • J. V. Haxby

There are no affiliations available

Personalised recommendations